JP2007326851A - Method of improving volatilization of heat-transpiring preparation and heat-transpiring preparation - Google Patents

Method of improving volatilization of heat-transpiring preparation and heat-transpiring preparation Download PDF

Info

Publication number
JP2007326851A
JP2007326851A JP2007122305A JP2007122305A JP2007326851A JP 2007326851 A JP2007326851 A JP 2007326851A JP 2007122305 A JP2007122305 A JP 2007122305A JP 2007122305 A JP2007122305 A JP 2007122305A JP 2007326851 A JP2007326851 A JP 2007326851A
Authority
JP
Japan
Prior art keywords
preparation
heat
volatilization
foaming agent
organic foaming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007122305A
Other languages
Japanese (ja)
Other versions
JP4593590B2 (en
Inventor
Mikihiko Shin
幹彦 新
Takahiro Hasegawa
隆啓 長谷川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Earth Corp
Original Assignee
Earth Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Earth Chemical Co Ltd filed Critical Earth Chemical Co Ltd
Priority to JP2007122305A priority Critical patent/JP4593590B2/en
Publication of JP2007326851A publication Critical patent/JP2007326851A/en
Application granted granted Critical
Publication of JP4593590B2 publication Critical patent/JP4593590B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a new method which improves the volatilization of chemicals in a heat-transpiring preparation without increasing the amount of the organic foaming agent used and a heat transpiring preparation using the method. <P>SOLUTION: The heat-transpiring preparation in which the chemicals are volatilized by the indirect heating of the mixture of the chemicals and the organic foaming agent contains 5-20 wt.% of an inorganic porous body acting as a volatilization aid to the total amount of the organic foaming agent. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、有機発泡剤による熱分解ガスの作用により薬剤を揮散させる加熱蒸散用製剤において、薬剤の揮散を優位に向上させることができる加熱蒸散用製剤の揮散向上方法、該揮散向上方法を用いた加熱蒸散用製剤に関する。   The present invention relates to a method for improving volatilization of a preparation for heating transpiration, which can improve the volatilization of the drug, in the preparation for heating transpiration that volatilizes the drug by the action of the pyrolysis gas by the organic foaming agent, and uses the method for improving volatilization. The present invention relates to a preparation for heat evaporation.

従来から室内、倉庫等のある程度の容積をもつ空間に存在する害虫を駆除するため、薬剤を隅々まで到達させることができる加熱蒸散用製剤が用いられている。この製剤は、アゾジカルボンアミド等の有機発泡剤を間接的に加熱することで熱分解させ、その熱分解ガスの作用により薬剤を効率的に揮散させるものである(例えば、特許文献1参照。)。   2. Description of the Related Art Conventionally, a preparation for heat transpiration that can reach every corner of a medicine has been used to control pests present in a space having a certain volume such as a room or a warehouse. In this preparation, an organic foaming agent such as azodicarbonamide is thermally decomposed by indirectly heating, and the agent is efficiently evaporated by the action of the pyrolysis gas (see, for example, Patent Document 1). .

特開昭53−130432号公報(第1−6頁)Japanese Patent Laid-Open No. 53-130432 (page 1-6)

前記の加熱蒸散剤用製剤では、薬剤の揮散は有機発泡剤の使用量に影響されることから、薬剤の揮散を高めるにはその使用量を増やせばよいと考えられていた。しかし、有機発泡剤の増加にともない煙の発生も増えるので、刺激を感じたり、火災報知器の誤作動を引き起こすこと等もあり必ずしもよいとは言えない。ところが薬剤の揮散を高めるための、これにかわる有効な手段はほとんど検討されていないのが実情である。
そこで本発明は、前記の加熱蒸散用製剤において、有機発泡剤の使用量を増やさなくても薬剤の揮散を向上させることができる新たな方法、およびこの方法を用いた加熱蒸散用製剤を提供するものである。
In the above-mentioned preparation for heat transpiration agent, since the volatilization of the drug is affected by the amount of the organic foaming agent used, it has been considered that the amount of use should be increased in order to increase the volatilization of the drug. However, since the generation of smoke increases with the increase in the organic foaming agent, it is not necessarily good because it may cause irritation or cause a malfunction of the fire alarm. However, the actual situation is that few effective means for increasing the volatilization of drugs have been studied.
Therefore, the present invention provides a new method capable of improving the volatilization of the medicine without increasing the amount of the organic foaming agent used in the preparation for heat evaporation, and a preparation for heat evaporation using this method. Is.

本発明者らは、上記課題を解決するため鋭意検討した結果、薬剤と有機発泡剤との混合物を間接的に加熱して、その混合物中にある薬剤を揮散させるための加熱蒸散用製剤において、特定の無機多孔体を所定量配合して用いることで薬剤の揮散を優位に向上させることを見出し本発明に至った。
すなわち、本発明は以下の(1)〜(5)の加熱蒸散用製剤の揮散向上方法及び(6)の加熱蒸散用製剤によって達成されるものである。(1)薬剤と有機発泡剤との混合物を間接的に加熱して、前記薬剤を揮散させるための加熱蒸散用製剤において、前記有機発泡剤の全量に対して、揮散向上剤として作用する無機多孔体を5〜20重量%となるように配合することを特徴とする加熱蒸散用製剤の揮散向上方法。(2)前記無機多孔体が無機焼成発泡体であることを特徴とする請求項1記載の加熱蒸散用製剤の揮散向上方法。(3)有機発泡剤を65〜80重量%配合した加熱蒸散用製剤であることを特徴とする(1)または(2)記載の加熱蒸散用製剤の揮散向上方法。(4)有機発泡剤としてアゾジカルボンアミドを配合した加熱蒸散用製剤であることを特徴とする(1)〜(3)のいずれかに記載の加熱蒸散用製剤の揮散向上方法。(5)薬剤としてピレスロイド系殺虫剤、カーバメイト系殺虫剤、オキサジアゾール系殺虫剤、及びスルホンアミド系殺虫剤の1種又は2種以上を配合した加熱蒸散用製剤であることを特徴とする(1)〜(4)のいずれか1つに記載の加熱蒸散用製剤の揮散向上方法。(6)(1)〜(5)のいずれか1つに記載された加熱蒸散用製剤の揮散向上方法により、薬剤の揮散が向上されたことを特徴とする加熱蒸散用製剤。
As a result of intensive studies to solve the above problems, the present inventors indirectly heated a mixture of a drug and an organic foaming agent, and in the preparation for heat evaporation for volatilizing the drug in the mixture, It has been found that the volatilization of the drug can be significantly improved by blending and using a specific amount of a specific inorganic porous material.
That is, the present invention is achieved by the following methods (1) to (5) for improving the volatilization of a heat transpiration preparation and (6) the heat transpiration preparation. (1) Inorganic heating that acts as a volatilization improver for the total amount of the organic foaming agent in a preparation for heat evaporation for indirectly heating a mixture of the chemical and the organic foaming agent to volatilize the chemical The volatilization improvement method of the preparation for heat | fever evaporation characterized by mix | blending a body so that it may become 5 to 20 weight%. (2) The method for improving volatilization of a preparation for heat evaporation according to claim 1, wherein the inorganic porous material is an inorganic fired foam. (3) The method for improving volatilization of a preparation for heat evaporation according to (1) or (2), wherein the preparation is for heat evaporation containing 65 to 80% by weight of an organic foaming agent. (4) The method for improving volatilization of a preparation for heat transpiration according to any one of (1) to (3), which is a preparation for heat transpiration in which azodicarbonamide is blended as an organic foaming agent. (5) It is a preparation for heat transpiration in which one or more of pyrethroid insecticides, carbamate insecticides, oxadiazole insecticides, and sulfonamide insecticides are blended as drugs ( The volatilization improvement method of the preparation for heat transpiration as described in any one of 1)-(4). (6) A preparation for heat transpiration, wherein the volatilization of the drug is improved by the method for improving volatilization of the preparation for heat transpiration described in any one of (1) to (5).

本発明の加熱蒸散用製剤の揮散向上方法により、より少ない有機発泡剤の使用量で、薬剤の揮散を優位に向上させることができる。また、煙の発生が抑えられるので、刺激が低減されて使用感が改善され、また火災報知器の誤作動等の問題も解消することができる加熱蒸散用製剤を提供することができる。   With the method for improving volatilization of the preparation for heat evaporation of the present invention, the volatilization of the drug can be improved with a smaller amount of the organic foaming agent. Moreover, since generation | occurrence | production of smoke is suppressed, irritation | stimulation is reduced, a usability | use_condition is improved, and the formulation for heat | fever evaporation which can also eliminate problems, such as malfunction of a fire alarm, can be provided.

本発明の加熱蒸散用製剤の揮散向上方法は、例えば、図1に示されるような、自己発熱装置1の形態で使用される加熱蒸散用製剤Bに用いるものである。
自己発熱装置1は、有底円筒状の外容器2を備えており、その底部から側部にかけて加水発熱物質Aが収容されている。外容器2は、底部に複数の通水孔を有し、通水孔は通水性を有する部材、例えば不織布シート3によって塞がれている。また、外容器2の内部は、仕切部材4により2つの空間に区画されている。仕切部材4は、円筒状で底部が略中空半球状を呈しており、その側壁が外容器2の周壁と同心状に配置されている。
加水発熱物質Aは、外容器2の周壁、仕切部材4及び不織布シート3とで形成される空間に充填され、仕切部材4の内部には加熱蒸散用薬剤Bが収容される。また、外容器2の上部開放面には、仕切部材4の上部開放面に相当する領域に複数の開口部が形成された蓋部材6が被冠されており、更に蓋部材6の開口部は通気孔を有する熱溶融樹脂フィルム7によって塞がれている。
加水発熱物質Aは水との反応により自己発熱する物質であり、例えば、酸化カルシウム(生石灰)が用いられる。従って、使用に際して、自己発熱装置1を水Wが入った容器20に入れることにより、水Wが通水孔を通じて外容器2に流入し、更に不織布シート3を浸透して加水発熱物質Aと接触し、そのとき発生した反応熱により加熱蒸散用製剤Bが加熱されて、有機発泡剤の熱分解ガスと一緒に薬剤が揮散して、熱溶融樹脂フィルム7の通気孔を通じて外部(室内等)に放出される。また、熱溶融樹脂フィルム7は加熱蒸散用製剤Bからの放熱並びに揮散した薬剤との接触により熱溶融するため、蒸散の比較的早い時期から、揮散した薬剤は煙となって蓋部材6の開口部を通じて効率良く外部に放出される。
The method for improving volatilization of the preparation for heat transpiration of the present invention is used for the preparation B for heat transpiration used in the form of the self-heating device 1 as shown in FIG.
The self-heating device 1 includes a cylindrical outer container 2 with a bottom, and a hydrothermal substance A is accommodated from the bottom to the side. The outer container 2 has a plurality of water holes at the bottom, and the water holes are closed by a member having water permeability, for example, a nonwoven fabric sheet 3. Further, the inside of the outer container 2 is partitioned into two spaces by a partition member 4. The partition member 4 is cylindrical and has a bottom that is substantially hollow hemispherical, and its side wall is disposed concentrically with the peripheral wall of the outer container 2.
The hydrothermal exothermic substance A is filled in a space formed by the peripheral wall of the outer container 2, the partition member 4, and the nonwoven fabric sheet 3, and the heat transpiration agent B is accommodated inside the partition member 4. Further, the upper open surface of the outer container 2 is covered with a lid member 6 in which a plurality of openings are formed in a region corresponding to the upper open surface of the partition member 4. It is blocked by a hot-melt resin film 7 having vent holes.
The hydrothermal exothermic substance A is a substance that self-heats by reaction with water. For example, calcium oxide (quick lime) is used. Therefore, in use, when the self-heating device 1 is placed in the container 20 containing the water W, the water W flows into the outer container 2 through the water passage hole, and further penetrates the nonwoven fabric sheet 3 and comes into contact with the hydrothermal substance A. Then, the heat-evaporating preparation B is heated by the reaction heat generated at that time, and the chemical is volatilized together with the pyrolysis gas of the organic foaming agent. Released. Further, since the heat-melting resin film 7 is thermally melted by heat radiation from the preparation B for heat transpiration and contact with the volatilized drug, the volatilized drug becomes smoke from a relatively early stage of transpiration, and the lid member 6 is opened. It is efficiently discharged to the outside through the section.

加熱蒸散用製剤は、薬剤と有機発泡剤とを混合し、結合剤等を用いて造粒したものからなるものであるが、本発明の揮散向上方法は、混合時に無機多孔体を有機発泡剤の全量に対して5〜20重量%、好ましくは5〜15重量%となるように配合するものである。これにより、薬剤の揮散を優位に向上させることができる。すなわち、無機多孔体は加熱蒸散用製剤における薬剤揮散向上剤として機能する。
さらに本発明の揮散向上方法により、加熱蒸散用製剤を間接加熱した際の煙の発生を抑えることができる。メカニズムの詳細は明らかではないが、有機発泡剤に対して無機多孔体を特定量配合することで、有機発泡剤の発泡温度が抑えられて煙の発生が抑えられるものではないかと推測される。
この他にも、使用時に焦げ臭や異臭が低減されるので、使用感に悪影響を及ぼさないものである。
The preparation for heat evaporation consists of a mixture of a drug and an organic foaming agent, and granulated using a binder or the like. The volatilization improving method of the present invention converts an inorganic porous material into an organic foaming agent at the time of mixing. 5 to 20% by weight, preferably 5 to 15% by weight based on the total amount of the above. Thereby, volatilization of a chemical | medical agent can be improved significantly. That is, the inorganic porous material functions as a chemical volatilization improver in the preparation for heat evaporation.
Furthermore, the volatilization improving method of the present invention can suppress the generation of smoke when the preparation for heat evaporation is indirectly heated. Although details of the mechanism are not clear, it is presumed that the foaming temperature of the organic foaming agent can be suppressed and the generation of smoke can be suppressed by adding a specific amount of the inorganic porous material to the organic foaming agent.
In addition, since a burning odor and a strange odor are reduced during use, the feeling of use is not adversely affected.

無機多孔体としては、パーライト、シラスバルーン等の無機焼成発泡体が好ましく、パーライトが特に好ましい。   As the inorganic porous material, inorganic fired foams such as pearlite and shirasu balloon are preferable, and pearlite is particularly preferable.

また、加熱蒸散用製剤において、有機発泡剤を65〜80重量%、好ましくは70〜80重量%配合した場合に、薬剤の揮散の向上がよく発揮される。
本発明における有機発泡剤としては、熱分解して窒素ガス等を発生して一緒に薬剤を揮散するものであればよく、300℃以下で発泡溶融してガスを発生するものが好ましい。例えば、アゾジカルボンアミド、ベンゼンスルホニルヒドラジド、P−トルエンスルホニルヒドラジド、P,P’−オキシビス(ベンゼンスルホニルヒドラジド)、ジニトロソペンタンメチレンテトラジン、N,N’−ジニトロソ−N,N’−ジメチルテレフタルアミド、トリヒドラジノトリアジン、アゾビスイソブチロニトリル、4,4’−アゾビスシアノバレリックアシッド、t−ブチルアゾホルムアミド、2,4−ビス−(アゾスルホニル)トルエン、2,2’−アゾビスイソブチロアミド、メチル−2,2’−アゾビスイソブチレート、2−(カルバモイルアゾ)イソブチロニトリル、1,1−アゾビスシクロヘキサンカルボニトリル等の1種又は2種以上が挙げられる。
なかでも、アゾジカルボンアミドを配合することで、薬剤の揮散をよりよくするとともに、拡散性をもよくするので好ましい。
Further, in the preparation for heat evaporation, when the organic foaming agent is blended in an amount of 65 to 80% by weight, preferably 70 to 80% by weight, the improvement of the volatilization of the drug is often exhibited.
The organic foaming agent in the present invention is not particularly limited as long as it thermally decomposes to generate nitrogen gas and the like to volatilize the chemical together, and is preferably one that foams and melts at 300 ° C. or lower to generate gas. For example, azodicarbonamide, benzenesulfonylhydrazide, P-toluenesulfonylhydrazide, P, P′-oxybis (benzenesulfonylhydrazide), dinitrosopentanemethylenetetrazine, N, N′-dinitroso-N, N′-dimethylterephthalamide , Trihydrazinotriazine, azobisisobutyronitrile, 4,4′-azobiscyanovaleric acid, t-butylazoformamide, 2,4-bis- (azosulfonyl) toluene, 2,2′-azobis Examples thereof include one or more of isobutyramide, methyl-2,2′-azobisisobutyrate, 2- (carbamoylazo) isobutyronitrile, 1,1-azobiscyclohexanecarbonitrile and the like.
Among these, blending azodicarbonamide is preferable because it improves the volatilization of the drug and also improves the diffusibility.

本発明の揮散向上方法に適した薬剤としては、前記有機発泡剤の熱分解ガスと一緒に揮散する殺虫剤、害虫忌避剤、除菌剤、消臭剤、香料等を用いることができる。
殺虫剤としては、例えば、天然ピレトリン、ピレトリン、アレスリン、フタルスリン、レスメトリン、フラメトリン、ペルメトリン、フェノトリン、シフェノトリン、プラレトリン、トランスフルトリン、メトフルトリン、プロフルトリン、イミプロトリン、エムペントリン、エトフェンプロックス、シラフルオフェン等のピレスロイド系殺虫剤;プロポクスル、カルバリル等のカーバメイト系殺虫剤;フェニトロチオン、DDVP等の有機リン系殺虫剤;メトキサジアゾン等のオキサジアゾール系殺虫剤;フィプロニル等のフェニルピラゾール系殺虫剤;イミダクロプリド、ジノテフラン等のネオニコチノイド系殺虫剤;アミドフルメト等のスルホンアミド系殺虫剤;クロルフェナピル等のピロール系化合物;メトプレン、ハイドロプレン等の昆虫幼若ホルモン様化合物;プレコセン等の抗幼若ホルモン様化合物;エクダイソン等の脱皮ホルモン様化合物;フィトンチッド、薄荷油、オレンジ油、桂皮油、丁子油等の精油類;IBTA、IBTE、四級アンモニウム塩、サリチル酸ベンジル等の1種又は2種以上が挙げられる。
中でもピレスロイド系殺虫剤、カーバメイト系殺虫剤、オキサジアゾール系殺虫剤およびスルホンアミド系殺虫剤が、揮散がよく向上されるので好ましく、特に、シフェノトリン、ペルメトリン、メトキサジアゾン、プロポクスル、アミドフルメト、エトフェンプロックスが好ましい。
As a chemical | medical agent suitable for the volatilization improvement method of this invention, an insecticide, a pest repellent, a disinfectant, a deodorant, a fragrance | flavor, etc. which volatilize with the pyrolysis gas of the said organic foaming agent can be used.
Examples of insecticides include natural pyrethrin, pyrethrin, allethrin, phthalthrin, resmethrin, framethrin, permethrin, phenothrin, ciphenothrin, praretrin, transfluthrin, methfluthrin, profluthrin, imiprothrin, empentrin, ethofenprox, and sylfluofen. Insecticides; Carbamate insecticides such as propoxur and carbaryl; Organophosphorus insecticides such as fenitrothion and DDVP; Oxadiazole insecticides such as metoxadiazone; Phenylpyrazole insecticides such as fipronil; Neonicochi such as imidacloprid and dinotefuran Noid insecticides; sulfonamide insecticides such as amidoflumet; pyrrole compounds such as chlorfenapyr; metoprene, hydroprene Insect juvenile hormone-like compounds; anti-juvenile hormone-like compounds such as plecosene; molting hormone-like compounds such as ecdysone; essential oils such as phytoncide, light-loading oil, orange oil, cinnamon oil, and clove oil; 1 type (s) or 2 or more types, such as ammonium salt and a benzyl salicylate, are mentioned.
Of these, pyrethroid insecticides, carbamate insecticides, oxadiazole insecticides, and sulfonamide insecticides are preferable because of their improved volatility, and in particular, ciphenothrin, permethrin, methoxadiazone, propoxle, amidoflumet, etofenprox. Is preferred.

害虫忌避剤としては、例えば、ディート、ジ−n−ブチルサクシネート、ヒドロキシアニソール、ロテノン、エチル−ブチルアセチルアミノプロピオネート等の1種又は2種以上が挙げられる。
殺菌除菌剤としては、例えば、イソプロピルメチルフェノール、パラオキシ安息香酸エステル、PCMX、IPBC、グルコン酸クロルヘキシジン、塩酸クロルヘキシジン、塩化ベンゼトニウム、塩化セチルピリジニウム等の1種又は2種以上が挙げられる。
消臭剤としては、例えば、メタクリル酸ラウリル、ゲラニルクロリネート、カテキン、ポリフェノール等の1種又は2種以上が挙げられる。
香料としては、例えば、ピネン、リモネン、リナロール、メントール、オイゲノール、ラベンダー等の1種又は2種以上が挙げられる。
これらの薬剤は、加熱蒸散用製剤に対して0.1〜30重量%となるように配合すればよい。
As a pest repellent, 1 type (s) or 2 or more types, such as a diet, di-n-butyl succinate, hydroxyanisole, rotenone, ethyl-butylacetylamino propionate, are mentioned, for example.
Examples of the bactericidal disinfectant include one or more of isopropylmethylphenol, p-hydroxybenzoate, PCMX, IPBC, chlorhexidine gluconate, chlorhexidine hydrochloride, benzethonium chloride, cetylpyridinium chloride, and the like.
Examples of the deodorant include one or more of lauryl methacrylate, geranyl chlorinate, catechin, polyphenol and the like.
Examples of the fragrance include one or more of pinene, limonene, linalool, menthol, eugenol, lavender and the like.
What is necessary is just to mix | blend these chemical | medical agents so that it may become 0.1 to 30 weight% with respect to the preparation for heat | fever evaporation.

本発明の加熱蒸散用製剤を製造するには、前記の薬剤、有機発泡剤、無機多孔体等が所定量となるように混合し、結合剤や溶剤等を用いて造粒、乾燥させて、顆粒剤、粉末剤、微細粒剤等とすればよい。
これらを造粒する際には、例えば、顆粒剤であれば粒径を約1〜5mmとするのがよい。
造粒の際に用いる結合剤として、例えば、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルメチルセルロース等のセルロース類;デンプン、スターチ等のデンプン系、アラビアゴム等の天然系高分子化合物;ポリビニルアルコール、ポリビニルピロリドン等の合成高分子化合物等の1種又は2種以上が挙げられる。
これらの結合剤は、加熱蒸散用製剤に対して0.5〜5重量%となるように配合すればよい。
In order to produce the preparation for heat transpiration of the present invention, the above-mentioned agent, organic foaming agent, inorganic porous body and the like are mixed so as to be a predetermined amount, granulated using a binder or a solvent, and dried. Granules, powders, fine granules, etc. may be used.
When granulating these, for example, in the case of granules, the particle size is preferably about 1 to 5 mm.
Examples of binders used for granulation include celluloses such as carboxymethylcellulose, hydroxymethylcellulose, and hydroxypropylmethylcellulose; starches such as starch and starch; natural polymer compounds such as gum arabic; polyvinyl alcohol, polyvinylpyrrolidone, and the like 1 type or 2 types or more, such as these synthetic polymer compounds.
What is necessary is just to mix | blend these binders so that it may become 0.5 to 5 weight% with respect to the preparation for heat | fever evaporation.

溶剤としては、例えば、水、エタノール、プロパノール、ベンジルアルコール等のアルコール類、流動パラフィン、n−パラフィン等のパラフィン類、ブチルジグリコール等のエーテル類、ミリスチン酸イソプロピル等のエステル類、グリセリン等の多価アルコール、N−メチルピロリドン、炭酸プロピレン等の1種又は2種以上が挙げられる。
なお薬剤は、造粒時に混合、練り込む以外にも、造粒後に噴霧、浸漬させて保持させることもできる。
Examples of the solvent include alcohols such as water, ethanol, propanol, and benzyl alcohol, paraffins such as liquid paraffin and n-paraffin, ethers such as butyl diglycol, esters such as isopropyl myristate, and glycerin. 1 type, or 2 or more types, such as a monohydric alcohol, N-methylpyrrolidone, a propylene carbonate, is mentioned.
In addition to mixing and kneading at the time of granulation, the drug can be held by spraying and dipping after granulation.

さらに必要に応じて、崩壊剤、防錆剤、安定化剤等を配合してもよく、例えば、パラオキシ安息香酸エステル、ステアリン酸エステル、乳酸エチル、サリチル酸クロロフェニル等の有機酸エステル;リンゴ酸、フマル酸、酒石酸、アジピン酸、コハク酸等の有機酸等の崩壊剤を用いると、加熱による製剤の崩壊が促進され、薬剤の揮散をスムーズとすることができる。
防錆剤としては、例えば、1,2,3−ベンゾトリアゾール、ジシクロヘキシルアンモニウムナイトライト等が挙げられる。
安定化剤としては、例えば、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール等が挙げられる。
この他にも、Cd−ステアレート、Ca−ステアレート、Zn−ステアレート、Zn−オクテート、ZnO、Sn−マレート、ZnCO、尿素、クロムエロー、カーボンブラック、DyphosおよびTribase(ナショナルリード社製)、OF−14およびOF−15(アデカアーガス社製)、KV−68A−1(共同薬品社製)、Mark−553(アデカケミ社製)、Sicostab60およびSicostab61(シーグレ社製)等を併用することで有機発泡剤の発泡温度を下げることもできる。
さらに必要であれば、各種界面活性剤、効力増強剤、色素等を用いることもできる。
Further, if necessary, disintegrating agents, rust preventives, stabilizers and the like may be blended. For example, organic acid esters such as paraoxybenzoic acid ester, stearic acid ester, ethyl lactate, chlorophenyl salicylate; malic acid, fumaric acid When a disintegrant such as an acid, tartaric acid, adipic acid, or organic acid such as succinic acid is used, disintegration of the preparation by heating is promoted, and the volatilization of the drug can be made smooth.
Examples of the rust inhibitor include 1,2,3-benzotriazole, dicyclohexylammonium nitrite and the like.
Examples of the stabilizer include dibutylhydroxytoluene, butylhydroxyanisole and the like.
In addition, Cd-stearate, Ca-stearate, Zn-stearate, Zn-octate, ZnO, Sn-maleate, ZnCO 3 , urea, chrome yellow, carbon black, Dyphos and Tribase (manufactured by National Lead), OF-14 and OF-15 (manufactured by Adeka Argus), KV-68A-1 (manufactured by Kyodo Yakuhin Co., Ltd.), Mark-553 (manufactured by Adeka Chemi), Sicostab 60 and Sicostab 61 (manufactured by Sigre), etc. are used in combination. The foaming temperature of the foaming agent can also be lowered.
Furthermore, if necessary, various surfactants, efficacy enhancers, dyes and the like can be used.

自己発熱装置1で用いる加水発熱物質Aとしては、例えば、塩化マグネシウム、塩化アルミニウム、酸化カルシウム等が挙げられる。このような発熱システムにおいては、加熱蒸散用製剤に対して加水発熱物質を1〜10重量倍を用いるのがよく、具体的には加熱蒸散用製剤5〜100gに対して加水発熱物質50〜300gを目安として用いるのがよい。さらに加水発熱物質に対して水は0.2〜2重量倍となるように加えればよい。   Examples of the hydrothermal exothermic substance A used in the self-heating device 1 include magnesium chloride, aluminum chloride, calcium oxide and the like. In such an exothermic system, it is preferable to use 1 to 10 times the hydropyrogenic substance with respect to the preparation for heat transpiration. Should be used as a guide. Further, water may be added so as to be 0.2 to 2 times by weight with respect to the hydrothermal substance.

本発明の加熱蒸散用製剤の使用形態としては、自己発熱装置1に限るものではなく、加水発熱物質と水との反応による発熱システムにかえて、例えば、ニクロム線等の電熱線、平板状やリング状、さらに半導体を利用した加熱ヒーター等を用いた電気加熱システム;鉄粉と塩素酸アンモニウム等の酸化剤とを混合する、金属と該金属よりイオン化傾向の小さい金属酸化物又は酸化剤とを混合する、鉄と硫酸カリウム、硫酸鉄、金属塩化物、硫化鉄等の混合物を水や酸素と接触させる、鉄よりイオン化傾向が大きい金属と鉄よりイオン化傾向が小さい金属のハロゲン化物との混合物を水と接触させる、金属と重硫酸塩との混合物を水と接触させる、アルミニウムとアルカリ金属硝酸塩との混合物に水を加える、等の酸化反応により発熱するシステム;硫酸ソーダと炭化鉄との混合物を酸素と接触させる金属硫化物の酸化反応を利用して発熱するシステム等を用いてもよい。
その際、加熱温度としては図1のX(仕切部材4の底部)で測定した時に約200〜500℃、好ましくは約300〜400℃とするのが好ましい。
The form of use of the preparation for heat evaporation of the present invention is not limited to the self-heating device 1, but instead of an exothermic system based on the reaction between a hydrothermal substance and water, for example, a heating wire such as a nichrome wire, a flat plate, An electric heating system using a ring-shaped, semiconductor-based heater or the like; a mixture of iron powder and an oxidizing agent such as ammonium chlorate, and a metal and a metal oxide or oxidizing agent having a lower ionization tendency than the metal Mix a mixture of iron and potassium sulfate, iron sulfate, metal chloride, iron sulfide, etc. with water or oxygen, and a mixture of a metal that has a higher ionization tendency than iron and a metal halide that has a lower ionization tendency than iron. Contact with water, contact a mixture of metal and bisulfate with water, add water to a mixture of aluminum and alkali metal nitrate, etc. Beam; may be used system and the like generate heat by utilizing an oxidation reaction of the mixture of the metal sulfide is contacted with oxygen in sodium sulfate and iron carbide.
At that time, the heating temperature is about 200 to 500 ° C., preferably about 300 to 400 ° C., as measured by X in FIG. 1 (the bottom of the partition member 4).

また加熱蒸散用製剤を収納する容器(仕切部材4)としては、例えば、プラスチック容器、紙容器、金属容器、セラミック容器、ガラス容器等を用いることができる。   Moreover, as a container (partition member 4) which accommodates the preparation for heating transpiration, a plastic container, a paper container, a metal container, a ceramic container, a glass container etc. can be used, for example.

以下に実施例によって本発明をさらに詳しく説明するが、本発明はこれらに限定されるものではない。   EXAMPLES The present invention will be described in more detail with reference to examples below, but the present invention is not limited to these examples.

試験例1
図1に示されるような、自己発熱装置1を8畳居室(32m)内の床面中央に設置し、蒸散開始から2時間後の殺虫剤の揮散量を測定し、揮散率を求めた。この試験では表1に記載した加熱蒸散用製剤10gを用い、酸化カルシウム65gに水22gを加えて揮散させた。揮散した殺虫剤は、捕集装置によりシリカゲルを用いて15分間捕集を行い、このシリカゲルより殺虫剤をアセトン1リットルを用いて抽出した。その後、抽出液を吸引濾過して濾過液に、ペルメトリンではセバシン酸ジエチルヘキシルを、メトキサジアゾンではセバシン酸ジブチルを加えてガスクロマトグラフで定量分析を行い、薬剤の揮散率(%)を求めた。試験は2回繰り返して行い、平均値を求めた。
Test example 1
The self-heating device 1 as shown in FIG. 1 was installed at the center of the floor in an 8 tatami room (32 m 3 ), and the volatilization rate of the insecticide 2 hours after the start of transpiration was measured to determine the volatilization rate. . In this test, 10 g of the preparation for heat evaporation described in Table 1 was used, and 22 g of water was added to 65 g of calcium oxide to volatilize. The volatilized insecticide was collected for 15 minutes using silica gel by a collection device, and the insecticide was extracted from the silica gel using 1 liter of acetone. Thereafter, the extract was suction filtered, and diethylhexyl sebacate was added to the filtrate by permethrin, and dibutyl sebacate was added to methoxadiazone, and quantitative analysis was performed by gas chromatography to obtain the volatilization rate (%) of the drug. The test was repeated twice to obtain an average value.

Figure 2007326851
Figure 2007326851

試験結果は表2に示した。有機発泡剤(アゾジカルボンアミド)に対して約11重量%のパーライトを配合した実施例1は、同量の無水ケイ酸を配合した比較例1と比べて、揮散率としてペルメトリンで約33%、メトキサジアゾンで約20%高かった。また実施例1は、参考例1と比べて有機発泡剤が10%も少ないにもかかわらず、ペルメトリンとメトキサジアゾンの両者で同等の揮散率が得られており、パーライトを配合することで薬剤の揮散が優位に向上されることが実証された。   The test results are shown in Table 2. Example 1 in which about 11% by weight of pearlite was blended with respect to the organic blowing agent (azodicarbonamide) was compared with Comparative Example 1 in which the same amount of silicic acid was blended, and the volatilization rate was about 33% with permethrin. About 20% higher for methoxadiazone. Further, in Example 1, although the organic foaming agent was 10% less than that in Reference Example 1, the same volatilization rate was obtained for both permethrin and methoxadiazone. Proved to be a significant improvement.

Figure 2007326851
Figure 2007326851

試験例2
実施例1において、有機発泡剤に対するパーライトの配合量をかえて、約5.3重量%(実施例2)、約17.6重量%(実施例3)、約25重量%(比較例2)として、試験例1と同じ試験を行なった。パーライトの増減量に伴ないアゾジカルボンアミドの配合量を調整し、製剤全量としては10gとなるようにした。
試験の結果は表3に示した。実施例のペルメトリンとメトキサジアゾンの揮散率はいずれも比較例1よりも向上した。とくに実施例2では参考例1と比べても同等以上であった。
Test example 2
In Example 1, the blending amount of perlite with respect to the organic foaming agent was changed to about 5.3% by weight (Example 2), about 17.6% by weight (Example 3), and about 25% by weight (Comparative Example 2). The same test as in Test Example 1 was performed. The blending amount of azodicarbonamide was adjusted with the increase / decrease amount of pearlite so that the total amount of the preparation was 10 g.
The test results are shown in Table 3. The volatilization rates of permethrin and methoxadiazone in the examples were both improved as compared with Comparative Example 1. In particular, Example 2 was equivalent or better than Reference Example 1.

Figure 2007326851
Figure 2007326851

試験例3
実施例1の加熱蒸散用製剤を用いて、殺虫効力を確認した。まず8畳居室(32m)の対角2箇所の床面に、クロゴキブリ雌成虫10匹/1箇所をスリットボックス内(10mm×100mmのスリットが2つある1辺が30cmの立方体)に設置し、実施例1の加熱蒸散用製剤を居室中央の床面に置いて揮散させた。2時間暴露させて経時的にノックダウン数を計数し、さらに24時間後の致死率(%)を算出した。試験は2回繰り返して行い、平均値を求めた。
試験結果は表4に示した。実施例1は、対照に用いた参考例1以上の殺虫効力を奏することが実証された。
Test example 3
The insecticidal efficacy was confirmed using the heat transpiration preparation of Example 1. First, on the floor of two diagonals in an 8 tatami room (32 m 3 ), 10 adult male black cockroaches / site are placed in a slit box (a cube with two 10 mm x 100 mm slits and a side of 30 cm). Then, the preparation for heating and transpiration of Example 1 was placed on the floor in the center of the room and volatilized. After 2 hours of exposure, the number of knockdowns was counted over time, and the mortality (%) after 24 hours was calculated. The test was repeated twice to obtain an average value.
The test results are shown in Table 4. Example 1 was demonstrated to exhibit the insecticidal efficacy of Reference Example 1 or more used as a control.

Figure 2007326851
Figure 2007326851

試験例4
8畳相当のチャンバー(32m)の中央の床面から高さ1mの場所に集塵計(SIBATA DIGITAL DUST INDICATOR MODEL P−5)を設置し、実施例1の加熱蒸散用製剤を用いて薬剤を揮散させて、120分後に煙量を1分間測定した。またブランクとして揮散前にチャンバー内の煙量を測定しておき、次式により煙量(c.p.m)を求めた。そして参考例1を対象として、減煙率(%)を算出した。試験は2回繰り返して行い、平均値を求めた。
煙量(c.p.m)=測定した煙量−ブランクの煙量
減煙率(%)=(対照の煙量−測定した煙量)÷対照の煙量
試験結果は表5に示した。実施例1は参考例1と比べてアゾジカルボンアミドが10%少ないのに対して、減煙率は30%を超えており、有機発泡剤の配合差を上回り煙が減少することがわかった。
Test example 4
A dust collector (SIBATA DIGITAL DUST INDICATOR MODEL P-5) is installed at a height of 1 m from the center floor of a chamber (32 m 3 ) equivalent to 8 tatami mats, and the drug using the preparation for heat evaporation of Example 1 is used. The amount of smoke was measured for 120 minutes after 120 minutes. Moreover, the amount of smoke in the chamber was measured as a blank before volatilization, and the amount of smoke (cpm) was determined by the following formula. The smoke reduction rate (%) was calculated for Reference Example 1. The test was repeated twice to obtain an average value.
Smoke amount (cpm) = measured smoke amount-blank smoke amount Smoke reduction rate (%) = (control smoke amount-measured smoke amount) / control smoke amount The test results are shown in Table 5. . In Example 1, the amount of azodicarbonamide was 10% less than that of Reference Example 1, whereas the smoke reduction rate exceeded 30%, and it was found that the smoke decreased more than the blending difference of the organic foaming agent.

Figure 2007326851
Figure 2007326851

試験例5
実施例1と、実施例1のパーライトを同量のタルク、カオリンに代えた加熱蒸散用製剤を製造し、図1に示されるような自己発熱装置1を用いて、8畳相当のチャンバー内(32m)の中央の床面に置いて揮散させた。2時間後に換気を10分間行なってチャンバー内にモニターが入り、焦げ臭、異臭についての官能評価を行なった。
モニター10人で評価した結果、カオリン、タルクの順で焦げ臭、異臭があると感じる傾向が見られたが、パーライトを用いた場合には焦げ臭、異臭は感じられず、使用感に優れることがわかった。
Test Example 5
A preparation for heating and transpiration was prepared by replacing the pearlite of Example 1 with the same amount of talc and kaolin in Example 1, and using a self-heating device 1 as shown in FIG. It was placed on the floor surface at the center of 32 m 3 ) and volatilized. After 2 hours, ventilation was performed for 10 minutes, and a monitor entered the chamber, and sensory evaluation was performed for burnt odor and odor.
As a result of evaluation with 10 monitors, there was a tendency to feel burnt odor and odor in the order of kaolin and talc, but when using perlite, burn odor and odor are not felt and it is excellent in use feeling I understood.

上記結果より、本願発明によれば加熱蒸散用製剤の揮散率が向上され、煙の発生も抑えられることが実証された。さらに、焦げ臭、異臭の低減効果や殺虫効力が向上することも確認された。   From the above results, it was proved that according to the present invention, the volatilization rate of the preparation for heat evaporation is improved and the generation of smoke is also suppressed. Furthermore, it was confirmed that the burning odor and odor reduction effect and insecticidal efficacy were improved.

試験例6
表6に示す配合とした他は試験例1と同様にして揮散率(%)を求めた。試験は2回繰り返して行い、平均値を求めた。結果を表7に示す。
Test Example 6
Except for the formulation shown in Table 6, the volatilization rate (%) was determined in the same manner as in Test Example 1. The test was repeated twice to obtain an average value. The results are shown in Table 7.

Figure 2007326851
Figure 2007326851

Figure 2007326851
Figure 2007326851

表7に示すような、薬剤の配合であっても、各薬剤の揮散率は十分に得られる結果となった。   Even if it was the mixing | blending of a chemical | medical agent as shown in Table 7, the result obtained that the volatilization rate of each chemical | medical agent was fully obtained.

試験例7
表8に示す配合とした他は試験例1と同様にして揮散率(%)を求めた。試験は2回繰り返して行い、平均値を求めた。結果を表9に示す。
Test Example 7
Except for the formulation shown in Table 8, the volatilization rate (%) was determined in the same manner as in Test Example 1. The test was repeated twice to obtain an average value. The results are shown in Table 9.

Figure 2007326851
Figure 2007326851

Figure 2007326851
Figure 2007326851

表9に示すような、薬剤の配合であっても、各薬剤の揮散率は十分に得られる結果となった。   Even if it was a chemical | medical agent mixing | blending as shown in Table 9, the result obtained that the volatilization rate of each chemical | medical agent was fully obtained.

<製剤例>
本発明の加熱蒸散用製剤の揮散向上方法を用いた加熱蒸散用製剤の製剤例を以下に示すが、本発明は発明の効果を奏する限りこれらに限られるものではない。
<Formulation example>
Examples of preparations for heat transpiration using the method for improving volatilization of preparations for heat transpiration according to the present invention are shown below, but the present invention is not limited to these as long as the effects of the invention are exhibited.

Figure 2007326851
Figure 2007326851

Figure 2007326851
Figure 2007326851

Figure 2007326851
Figure 2007326851

Figure 2007326851
Figure 2007326851

Figure 2007326851
Figure 2007326851

Figure 2007326851
Figure 2007326851

加熱蒸散用製剤の一使用形態を示す断面図である。It is sectional drawing which shows one use form of the preparation for heat transpiration.

符号の説明Explanation of symbols

1 自己発熱装置
2 外容器
3 不織布シート
4 仕切部材
6 蓋部材
7 熱溶融フィルム
20 容器
A 加水発熱物質
B 加熱蒸散用製剤
W 水
DESCRIPTION OF SYMBOLS 1 Self-heating device 2 Outer container 3 Nonwoven fabric sheet 4 Partition member 6 Lid member 7 Heat-melt film 20 Container A Hydrothermal substance B Heating transpiration preparation W Water

Claims (6)

薬剤と有機発泡剤との混合物を間接的に加熱して、前記薬剤を揮散させるための加熱蒸散用製剤において、前記有機発泡剤の全量に対して、揮散向上剤として作用する無機多孔体を5〜20重量%となるように配合することを特徴とする加熱蒸散用製剤の揮散向上方法。   In the preparation for heat evaporation for heating the mixture of the chemical and the organic foaming agent indirectly to volatilize the chemical, 5 inorganic porous bodies that act as volatilization improvers with respect to the total amount of the organic foaming agent. A method for improving volatilization of a preparation for heat transpiration, which is blended so as to be ˜20% by weight. 前記無機多孔体が無機焼成発泡体であることを特徴とする請求項1記載の加熱蒸散用製剤の揮散向上方法。   2. The method for improving volatilization of a preparation for heat evaporation according to claim 1, wherein the inorganic porous material is an inorganic fired foam. 有機発泡剤を65〜80重量%配合した加熱蒸散用製剤であることを特徴とする請求項1または2に記載の加熱蒸散用製剤の揮散向上方法。   The method for improving volatilization of a preparation for heat evaporation according to claim 1 or 2, wherein the preparation is for heat evaporation containing 65 to 80% by weight of an organic foaming agent. 有機発泡剤としてアゾジカルボンアミドを配合した加熱蒸散用製剤であることを特徴とする請求項1〜3のいずれか1項に記載の加熱蒸散用製剤の揮散向上方法。   The method for improving volatilization of a preparation for heat evaporation according to any one of claims 1 to 3, wherein the preparation is for heat evaporation containing azodicarbonamide as an organic foaming agent. 薬剤としてピレスロイド系殺虫剤、カーバメイト系殺虫剤、オキサジアゾール系殺虫剤及びスルホンアミド系殺虫剤の1種又は2種以上を配合した加熱蒸散用製剤であることを特徴とする請求項1〜4のいずれか1項に記載の加熱蒸散用製剤の揮散向上方法。   5. A heat transpiration preparation comprising one or more pyrethroid insecticides, carbamate insecticides, oxadiazole insecticides and sulfonamide insecticides as a drug. The volatilization improvement method of the preparation for heat | fever evaporation of any one of these. 請求項1〜5のいずれか1項に記載の加熱蒸散用製剤の揮散向上方法により、薬剤の揮散が向上されたことを特徴とする加熱蒸散用製剤。   6. A preparation for heat transpiration, wherein the volatilization of the drug is improved by the method for improving volatilization of the preparation for heat transpiration according to any one of claims 1 to 5.
JP2007122305A 2006-05-12 2007-05-07 Method for improving volatilization of preparations for heat evaporation Active JP4593590B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007122305A JP4593590B2 (en) 2006-05-12 2007-05-07 Method for improving volatilization of preparations for heat evaporation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006133669 2006-05-12
JP2007122305A JP4593590B2 (en) 2006-05-12 2007-05-07 Method for improving volatilization of preparations for heat evaporation

Publications (2)

Publication Number Publication Date
JP2007326851A true JP2007326851A (en) 2007-12-20
JP4593590B2 JP4593590B2 (en) 2010-12-08

Family

ID=38927572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007122305A Active JP4593590B2 (en) 2006-05-12 2007-05-07 Method for improving volatilization of preparations for heat evaporation

Country Status (1)

Country Link
JP (1) JP4593590B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014088013A1 (en) 2012-12-03 2014-06-12 アース製薬株式会社 Device for spraying powdery chemical agent and process for spraying powdery chemical agent
WO2014171522A1 (en) 2013-04-17 2014-10-23 アース製薬株式会社 Injection device for powdered drugs and injection method for powdered drugs
JP2015044876A (en) * 2014-12-08 2015-03-12 ライオン株式会社 Antifungal smoking agent composition for bathroom and antifungal smoking device for bathroom
JP2015057412A (en) * 2014-10-31 2015-03-26 ライオン株式会社 Smoking agent composition for indirect heating and direct heating type smoking device
JP2015091876A (en) * 2015-02-04 2015-05-14 ライオン株式会社 Antifungal smoking apparatus for bath room
JP2015096524A (en) * 2014-12-08 2015-05-21 ライオン株式会社 Antifungal smoking agent composition for bath room and antifungal smoking device for bath room
JP2016069368A (en) * 2014-09-30 2016-05-09 アース製薬株式会社 Indoor sterilization method
CN104822261B (en) * 2012-12-03 2016-11-30 阿斯制药株式会社 Mealy medicine injection apparatus and mealy medicine injection method
JP2016209533A (en) * 2014-09-30 2016-12-15 アース製薬株式会社 Sterilization method of bathroom
JP2018109072A (en) * 2015-12-25 2018-07-12 アース製薬株式会社 Heating transpiration agent

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849304A (en) * 1981-09-18 1983-03-23 Matsumoto Seiyaku Kogyo Kk Fumigating insecticide
JP2000169310A (en) * 1998-12-10 2000-06-20 Sumitomo Chem Co Ltd Acaricide composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849304A (en) * 1981-09-18 1983-03-23 Matsumoto Seiyaku Kogyo Kk Fumigating insecticide
JP2000169310A (en) * 1998-12-10 2000-06-20 Sumitomo Chem Co Ltd Acaricide composition

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014088013A1 (en) 2012-12-03 2014-06-12 アース製薬株式会社 Device for spraying powdery chemical agent and process for spraying powdery chemical agent
CN104822261A (en) * 2012-12-03 2015-08-05 阿斯制药株式会社 Device for spraying powdery chemical agent and process for spraying powdery chemical agent
CN104822261B (en) * 2012-12-03 2016-11-30 阿斯制药株式会社 Mealy medicine injection apparatus and mealy medicine injection method
WO2014171522A1 (en) 2013-04-17 2014-10-23 アース製薬株式会社 Injection device for powdered drugs and injection method for powdered drugs
KR20150143511A (en) 2013-04-17 2015-12-23 아스세이야쿠가부시키가이샤 Injection device for powdered drugs and injection method for powdered drugs
JP2016069368A (en) * 2014-09-30 2016-05-09 アース製薬株式会社 Indoor sterilization method
JP2016209533A (en) * 2014-09-30 2016-12-15 アース製薬株式会社 Sterilization method of bathroom
JP2015057412A (en) * 2014-10-31 2015-03-26 ライオン株式会社 Smoking agent composition for indirect heating and direct heating type smoking device
JP2015044876A (en) * 2014-12-08 2015-03-12 ライオン株式会社 Antifungal smoking agent composition for bathroom and antifungal smoking device for bathroom
JP2015096524A (en) * 2014-12-08 2015-05-21 ライオン株式会社 Antifungal smoking agent composition for bath room and antifungal smoking device for bath room
JP2015091876A (en) * 2015-02-04 2015-05-14 ライオン株式会社 Antifungal smoking apparatus for bath room
JP2018109072A (en) * 2015-12-25 2018-07-12 アース製薬株式会社 Heating transpiration agent

Also Published As

Publication number Publication date
JP4593590B2 (en) 2010-12-08

Similar Documents

Publication Publication Date Title
JP4593590B2 (en) Method for improving volatilization of preparations for heat evaporation
KR20150027029A (en) Smoking agent and smoking device
JP7076028B2 (en) Heat transpiration agent
JPS5828842B2 (en) Pest control method
JP5172394B2 (en) Smoking agent composition and smoking method
JPH1192312A (en) Smoking insecticide and smoking
JP7051967B2 (en) Disinfectant
JP2003070404A (en) Smoking insecticide and method for smoking by using the same
JP5887395B2 (en) Mold anti-smoke composition for bathroom and anti-smoke device for bathroom
JP2000351702A (en) Smoking insecticidal composition
JP6322176B2 (en) Disinfection method
JPS5842841B2 (en) Pest control method
JP2015091876A (en) Antifungal smoking apparatus for bath room
JP2022016925A (en) Heat transpiration agent
JP6489696B2 (en) Indirect heating smoke composition
WO2022019337A1 (en) Virus inactivating agent and virus inactivation method
JP7368106B2 (en) smoking device
JP3608679B2 (en) Pest control fumigant
JPS60130501A (en) Fumigating agent composition
JP5002840B2 (en) Propoxle volatilization rate improver and method to improve propoxle volatilization rate
JP2007117950A (en) Burnt odor preventing agent
JPH0117181Y2 (en)
JP2000342155A (en) Smoking insecticide for use under floor and smoking of site under floor using the same
JPS61215301A (en) Cockroach-controlling agent composition
JP2002193703A (en) Stabilizer for fumigant composition and method for preventing contamination after conducting fumigation treatment

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071129

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100817

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100907

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100915

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130924

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4593590

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250